234 related articles for article (PubMed ID: 29983414)
1. Caffeine: an evidence-based success story in VLBW pharmacotherapy.
Dobson NR; Hunt CE
Pediatr Res; 2018 Sep; 84(3):333-340. PubMed ID: 29983414
[TBL] [Abstract][Full Text] [Related]
2. Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
Schmidt B; Roberts RS; Anderson PJ; Asztalos EV; Costantini L; Davis PG; Dewey D; D'Ilario J; Doyle LW; Grunau RE; Moddemann D; Nelson H; Ohlsson A; Solimano A; Tin W;
JAMA Pediatr; 2017 Jun; 171(6):564-572. PubMed ID: 28437520
[TBL] [Abstract][Full Text] [Related]
3. Current options in the management of apnea of prematurity.
Bhatia J
Clin Pediatr (Phila); 2000 Jun; 39(6):327-36. PubMed ID: 10879934
[TBL] [Abstract][Full Text] [Related]
4. Evidence-based methylxanthine use in the NICU.
Spitzer AR
Clin Perinatol; 2012 Mar; 39(1):137-48. PubMed ID: 22341542
[TBL] [Abstract][Full Text] [Related]
5. Caffeine for apnea of prematurity.
Hand IL; Noble LM
N Engl J Med; 2006 Aug; 355(9):959; author reply 959-60. PubMed ID: 16948188
[No Abstract] [Full Text] [Related]
6. Long-term effects of caffeine therapy for apnea of prematurity.
Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
N Engl J Med; 2007 Nov; 357(19):1893-902. PubMed ID: 17989382
[TBL] [Abstract][Full Text] [Related]
7. Caffeine therapy for apnea of prematurity.
Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
N Engl J Med; 2006 May; 354(20):2112-21. PubMed ID: 16707748
[TBL] [Abstract][Full Text] [Related]
8. Caffeine for apnea of prematurity: a neonatal success story.
Kreutzer K; Bassler D
Neonatology; 2014; 105(4):332-6. PubMed ID: 24931325
[TBL] [Abstract][Full Text] [Related]
9. Caffeine citrate: when and for how long. A literature review.
Picone S; Bedetta M; Paolillo P
J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 3():11-4. PubMed ID: 23016611
[TBL] [Abstract][Full Text] [Related]
10. Caffeine controversies.
Gentle SJ; Travers CP; Carlo WA
Curr Opin Pediatr; 2018 Apr; 30(2):177-181. PubMed ID: 29346141
[TBL] [Abstract][Full Text] [Related]
11. On the caffeination of prematurity.
Stevenson DK
N Engl J Med; 2007 Nov; 357(19):1967-8. PubMed ID: 17989390
[No Abstract] [Full Text] [Related]
12. National and international guidelines for neonatal caffeine use: Are they evidenced-based?
Eichenwald EC
Semin Fetal Neonatal Med; 2020 Dec; 25(6):101177. PubMed ID: 33214064
[TBL] [Abstract][Full Text] [Related]
13. Caffeine for apnea of prematurity.
Bancalari E
N Engl J Med; 2006 May; 354(20):2179-81. PubMed ID: 16707756
[No Abstract] [Full Text] [Related]
14. Methylxanthine use for apnea of prematurity among an international cohort of neonatologists.
Abu Jawdeh EG; O'Riordan M; Limrungsikul A; Bandyopadhyay A; Argus BM; Nakad PE; Supapannachart S; Yunis KA; Davis PG; Martin RJ
J Neonatal Perinatal Med; 2013; 6(3):251-6. PubMed ID: 24246598
[TBL] [Abstract][Full Text] [Related]
15. Caffeine Therapy in Preterm Infants: The Dose (and Timing) Make the Medicine.
Rostas SE; McPherson C
Neonatal Netw; 2019 Nov; 38(6):365-374. PubMed ID: 31712401
[TBL] [Abstract][Full Text] [Related]
16. Long-term neurodevelopment outcome of caffeine versus aminophylline therapy for apnea of prematurity.
Khurana S; Shivakumar M; Sujith Kumar Reddy GV; Jayashree P; Ramesh Bhat Y; Lewis LES
J Neonatal Perinatal Med; 2017; 10(4):355-362. PubMed ID: 29286928
[TBL] [Abstract][Full Text] [Related]
17. Neurobehavioral Outcomes 11 Years After Neonatal Caffeine Therapy for Apnea of Prematurity.
Mürner-Lavanchy IM; Doyle LW; Schmidt B; Roberts RS; Asztalos EV; Costantini L; Davis PG; Dewey D; D'Ilario J; Grunau RE; Moddemann D; Nelson H; Ohlsson A; Solimano A; Tin W; Anderson PJ;
Pediatrics; 2018 May; 141(5):. PubMed ID: 29643070
[TBL] [Abstract][Full Text] [Related]
18. Neurodevelopmental outcomes after neonatal caffeine therapy.
Synnes A; Grunau RE
Semin Fetal Neonatal Med; 2020 Dec; 25(6):101160. PubMed ID: 33121916
[TBL] [Abstract][Full Text] [Related]
19. Childhood respiratory outcomes after neonatal caffeine therapy.
Cheong JLY; Doyle LW
Semin Fetal Neonatal Med; 2020 Dec; 25(6):101158. PubMed ID: 33127315
[TBL] [Abstract][Full Text] [Related]
20. Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.
Schoen K; Yu T; Stockmann C; Spigarelli MG; Sherwin CM
Paediatr Drugs; 2014 Apr; 16(2):169-77. PubMed ID: 24399614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]